Article
Fcγ receptors and immunomodulatory antibodies in cancer - Nature Reviews Cancer
Rating:
0.0
Views:
38
Likes:
1
Library:
1
The discovery of both cytotoxic T lymphocyte-associated antigen 4 (CTLA4) and programmed cell death protein 1 (PD1) as negative regulators of antitumour immunity led to the development of numerous immunomodulatory antibodies as cancer treatments.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value